SCHEMBL31201289

SCHEMBL31201289

CC[C@H](CO)Nc1cc(NCCc2ccccn2)c2nnc(C3CC3)n2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 5/20 0.42
▸ GABRG2 P18507 5/20 0.42
▸ GABRB3 P28472 5/20 0.42
▸ GABRA5 P31644 5/20 0.42
▸ GABRA3 P34903 5/20 0.42
▸ GABRA2 P47869 5/20 0.42
▸ DYRK1A Q13627 7/20 0.37
▸ CDK2 P24941 6/20 0.37
▸ CDK7 P50613 2/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CCNH P51946 1/20 0.37
▸ MKNK1 Q9BUB5 2/20 0.36
▸ DYRK3 O43781 6/20 0.35
▸ CCNT1 O60563 6/20 0.35
▸ CDK9 P50750 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201357 0.95 GABRG2 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201279 0.91 CDK2 (0.43) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201241 0.91 CDK2 (0.43) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201343 0.86 GABRG2 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201188 0.82 GABRA1 (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201209 0.82 GABRA1 (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201161 0.82 CDK7 (0.49) DYRK1ACDK2CDK7CDK1CDK4
SCHEMBL31201070 0.82 CACNA2D1 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201529 0.82 GABRA1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31201327 0.80 FLT3 (0.35) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP claimed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO claimed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP claimed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 — — EP disclosed
WO-2024256496-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT PERHA PHARMACEUTICALS (FR) 2024-12-19 — — WO disclosed
EP-4477653-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2024-12-18 — — EP disclosed
Send feedback